Avenue Therapeutics Inc (ATXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,696 | -10,488 | -3,603 | -3,731 | -5,151 |
| Accounts receivable | N/A | N/A | 90 | N/A | N/A |
| Other Working Capital | 179 | -290 | 408 | -461 | -172 |
| Other Operating Activity | 2,491 | 1,327 | -4,491 | 442 | 710 |
| Operating Cash Flow | $-9,026 | $-9,451 | $-7,596 | $-3,750 | $-4,613 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | -3,000 | 0 | 0 | -1,000 |
| Investing Cash Flow | $N/A | $-3,000 | $N/A | $N/A | $-1,000 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 11,044 | 7,526 | 11,645 | 5,044 | N/A |
| Common Stock Repurchased | N/A | N/A | -1,104 | N/A | N/A |
| Other Financing Activity | -1,207 | 0 | 0 | -663 | 0 |
| Financing Cash Flow | $9,837 | $7,526 | $10,541 | $4,381 | $0 |
| Beginning Cash Position | 1,783 | 6,708 | 3,763 | 3,132 | 8,745 |
| End Cash Position | 2,594 | 1,783 | 6,708 | 3,763 | 3,132 |
| Net Cash Flow | $811 | $-4,925 | $2,945 | $631 | $-5,613 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,026 | -9,451 | -7,596 | -3,750 | -4,613 |
| Free Cash Flow | -9,026 | -9,451 | -7,596 | -3,750 | -4,613 |